What to look for when Progenics Pharma posts Q2 earnings
Progenics Pharmaceuticals (NASDAQ: PGNX) is set to release its earnings results for the second quarter of 2019 on Friday before...
Other Industries
Lumber Liquidators misses Q2 sales estimates; lowers FY19 sales outlook
Lumber Liquidators’ (NYSE: LL) second quarter top-line missed analysts’ estimates, while the bottom line was in line with the expectations....
Intercept Pharmaceuticals beats in Q2, keeps full-year outlook unchanged
Intercept Pharmaceuticals (NASDAQ: ICPT) on Wednesday reported second-quarter results that surpassed Wall Street expectations, riding on the strong growth of...
Ionis Pharmaceuticals stock surges on Q2 earnings beat
Ionis Pharmaceuticals (NASDAQ: IONS) reported better-than-expected second quarter results pushing the stock above 3% in the pre-market trading hours. The...
Teva’s Q2 results beat market expectations
Teva Pharmaceutical Industries (NYSE: TEVA) topped revenue and earnings estimates for the second quarter of 2019, giving shares a lift...
Earnings: CVS Health Q2 results beat estimates; raises FY19 guidance
Revenues of healthcare company CVS Health (NYSE: CVS) rose sharply in the second quarter and exceeded the estimates. As a...
Wynn Resorts Q2 earnings in line with estimates
Wynn Resorts (NASDAQ: WYNN) stock surged above 4% after the bell after the casino operator reported better-than-expected second quarter results....
GW Pharmaceuticals beats revenue estimates in Q2
GW Pharmaceuticals (NASDAQ: GWPH)topped revenue estimates for the second quarter of 2019, sending the stock climbing over 11% during aftermarket...
Weight Watchers stock jumps after lifting FY19 earnings outlook
Weight Watchers International (NASDAQ: WW) second quarter 2019 earnings surpassed the Street’s estimates, while revenue missed the predictions. WW stock...
New study shows cord-cutting in the US will continue to increase
A new report from eMarketer suggests that the trend of cord-cutting in the US will continue to increase at a...
Earnings preview: What to expect when Yelp reports Q2 results
Yelp Inc. (NYSE: YELP) is scheduled to report second quarter 2019 earnings results on Thursday, August 8, after market close....
Earnings Preview: The Trade Desk expected to continue the momentum in Q2
The Trade Desk (NASDAQ: TTD) has been having a dream run in the bourses this year with the stock surging...
Aurora Cannabis reiterates revenue outlook for Q4, FY19
Cannabis producer Aurora Cannabis (NYSE: ACB) reiterated its production and revenue guidance for the fourth quarter and fiscal 2019 after...
Alnylam Pharmaceuticals posts narrower-than-expected Q2 loss
Alnylam Pharmaceuticals (NASDAQ: ALNY) reported a wider loss in the second quarter of 2019 due to higher costs and expenses....
Bausch Health stock rises on guidance hike
Bausch Health Companies Inc. (NYSE: BHC) said its revenues for the second quarter edged up 1% to $2.15 billion, in...
Vericel reports Q2 earnings beat, raises outlook
Vericel Corporation (NASDAQ: VCEL) reported better-than-expected results in the second quarter aided by strong growth from both of its products....
Chesapeake Energy swings to profit in Q2
Chesapeake Energy Corporation (NYSE: CHK) swung to profit in the second quarter from a loss last year, driven by higher oil...
Allergan tops Q2 views; lifts 2019 revenue outlook
Allergan plc (NYSE: AGN) surpassed market’s expecations for Q2. The company also lifted its revenue outlook for full-year 2019. Non-GAAP...
Plug Power Q2 loss narrows on strong revenue growth, beats Steet view
Alternative energy technology company Plug Power (NASDAQ: PLUG) reported a narrower net loss for the second quarter of 2019, aided...
Regeneron Q2 earnings, revenue top expectations on strong product sales
Regeneron Pharmaceuticals (NASDAQ: REGN) reported an increase in earnings for the second quarter, when revenues grew by 20% helped by...
Marriott Q2 earnings in line with estimates, but revenue fails to impress
Marriott International (NASDAQ: MAR) stock slipped about 3% after the bell as the second quarter earnings came in line with...